| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein antigen binding | 3.22e-05 | 16 | 79 | 3 | GO:1990405 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 9.23e-05 | 4 | 79 | 2 | GO:0030197 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.01e-04 | 188 | 79 | 6 | GO:0005201 | |
| GeneOntologyCellularComponent | postsynaptic density | 4.57e-05 | 451 | 78 | 9 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 7.03e-05 | 477 | 78 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.05e-04 | 503 | 78 | 9 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.41e-04 | 523 | 78 | 9 | GO:0098984 | |
| GeneOntologyCellularComponent | cell surface | HSPD1 SLIT2 HAVCR1 NPTN LRFN2 ANK3 CLU MUC17 HLA-DQB2 NCAM1 SIRPA FCRL5 EPHA4 | 2.21e-04 | 1111 | 78 | 13 | GO:0009986 |
| GeneOntologyCellularComponent | growth cone | 3.10e-04 | 245 | 78 | 6 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 3.67e-04 | 253 | 78 | 6 | GO:0030427 | |
| Domain | - | HAVCR1 HSPG2 NPTN COL12A1 LRFN2 PTPRF HMCN1 LRIG1 HLA-DQB1 HLA-DQB2 NCAM1 SIGLEC1 SIRPA FCRL5 LRIT1 EPHA4 | 9.68e-09 | 663 | 77 | 16 | 2.60.40.10 |
| Domain | IG_LIKE | HAVCR1 HSPG2 NPTN LRFN2 PTPRF HMCN1 LRIG1 HLA-DQB1 HLA-DQB2 NCAM1 SIGLEC1 SIRPA FCRL5 LRIT1 | 1.16e-08 | 491 | 77 | 14 | PS50835 |
| Domain | Ig-like_dom | HAVCR1 HSPG2 NPTN LRFN2 PTPRF HMCN1 LRIG1 HLA-DQB1 HLA-DQB2 NCAM1 SIGLEC1 SIRPA FCRL5 LRIT1 | 1.57e-08 | 503 | 77 | 14 | IPR007110 |
| Domain | Ig-like_fold | HAVCR1 HSPG2 NPTN COL12A1 LRFN2 PTPRF HMCN1 LRIG1 HLA-DQB1 HLA-DQB2 NCAM1 SIGLEC1 SIRPA FCRL5 LRIT1 EPHA4 | 2.33e-08 | 706 | 77 | 16 | IPR013783 |
| Domain | IGc2 | HSPG2 NPTN LRFN2 PTPRF HMCN1 LRIG1 NCAM1 SIGLEC1 FCRL5 LRIT1 | 4.31e-08 | 235 | 77 | 10 | SM00408 |
| Domain | Ig_sub2 | HSPG2 NPTN LRFN2 PTPRF HMCN1 LRIG1 NCAM1 SIGLEC1 FCRL5 LRIT1 | 4.31e-08 | 235 | 77 | 10 | IPR003598 |
| Domain | Ig_I-set | 8.58e-08 | 190 | 77 | 9 | IPR013098 | |
| Domain | I-set | 8.58e-08 | 190 | 77 | 9 | PF07679 | |
| Domain | IG | HAVCR1 HSPG2 NPTN LRFN2 PTPRF HMCN1 LRIG1 NCAM1 SIGLEC1 SIRPA FCRL5 LRIT1 | 1.44e-07 | 421 | 77 | 12 | SM00409 |
| Domain | Ig_sub | HAVCR1 HSPG2 NPTN LRFN2 PTPRF HMCN1 LRIG1 NCAM1 SIGLEC1 SIRPA FCRL5 LRIT1 | 1.44e-07 | 421 | 77 | 12 | IPR003599 |
| Domain | ig | 1.33e-05 | 190 | 77 | 7 | PF00047 | |
| Domain | Immunoglobulin | 1.33e-05 | 190 | 77 | 7 | IPR013151 | |
| Domain | SEA | 2.37e-05 | 14 | 77 | 3 | SM00200 | |
| Domain | Cys-rich_flank_reg_C | 3.49e-05 | 90 | 77 | 5 | IPR000483 | |
| Domain | LRRCT | 3.49e-05 | 90 | 77 | 5 | SM00082 | |
| Domain | LRRNT | 5.26e-05 | 98 | 77 | 5 | IPR000372 | |
| Domain | LRRNT | 5.26e-05 | 98 | 77 | 5 | SM00013 | |
| Domain | fn3 | 5.53e-05 | 162 | 77 | 6 | PF00041 | |
| Domain | Neural_cell_adh | 1.00e-04 | 4 | 77 | 2 | IPR009138 | |
| Domain | SEA | 1.12e-04 | 23 | 77 | 3 | PS50024 | |
| Domain | SEA_dom | 1.12e-04 | 23 | 77 | 3 | IPR000082 | |
| Domain | FN3 | 1.15e-04 | 185 | 77 | 6 | SM00060 | |
| Domain | FN3 | 1.72e-04 | 199 | 77 | 6 | PS50853 | |
| Domain | FN3_dom | 2.24e-04 | 209 | 77 | 6 | IPR003961 | |
| Domain | LRRCT | 3.07e-04 | 32 | 77 | 3 | PF01463 | |
| Domain | MHC_II_b_N | 4.62e-04 | 8 | 77 | 2 | PD000328 | |
| Domain | MHC_II_beta | 5.93e-04 | 9 | 77 | 2 | PF00969 | |
| Domain | MHC_II_b_N | 5.93e-04 | 9 | 77 | 2 | IPR000353 | |
| Domain | MHC_II_beta | 5.93e-04 | 9 | 77 | 2 | SM00921 | |
| Domain | - | 6.40e-04 | 95 | 77 | 4 | 2.60.120.200 | |
| Domain | LRR_8 | 7.04e-04 | 171 | 77 | 5 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 8.23e-04 | 177 | 77 | 5 | IPR003591 | |
| Domain | LRR_TYP | 8.23e-04 | 177 | 77 | 5 | SM00369 | |
| Domain | Laminin_G_1 | 9.01e-04 | 11 | 77 | 2 | PF00054 | |
| Domain | Ig_V-set | 1.39e-03 | 199 | 77 | 5 | IPR013106 | |
| Domain | C1-set | 1.44e-03 | 54 | 77 | 3 | PF07654 | |
| Domain | LRR | 1.45e-03 | 201 | 77 | 5 | PS51450 | |
| Domain | MHC_II_a/b_N | 1.48e-03 | 14 | 77 | 2 | IPR014745 | |
| Domain | PB1 | 1.48e-03 | 14 | 77 | 2 | SM00666 | |
| Domain | PB1 | 1.48e-03 | 14 | 77 | 2 | PF00564 | |
| Domain | - | 1.48e-03 | 14 | 77 | 2 | 3.10.320.10 | |
| Domain | PB1 | 1.48e-03 | 14 | 77 | 2 | PS51745 | |
| Domain | PB1_dom | 1.48e-03 | 14 | 77 | 2 | IPR000270 | |
| Domain | IGc1 | 1.60e-03 | 56 | 77 | 3 | SM00407 | |
| Domain | Laminin_G | 1.77e-03 | 58 | 77 | 3 | IPR001791 | |
| Domain | Ig_C1-set | 1.77e-03 | 58 | 77 | 3 | IPR003597 | |
| Domain | Ig/MHC_CS | 1.77e-03 | 58 | 77 | 3 | IPR003006 | |
| Domain | IG_MHC | 1.95e-03 | 60 | 77 | 3 | PS00290 | |
| Domain | LRR_1 | 2.11e-03 | 219 | 77 | 5 | PF00560 | |
| Domain | EGF_3 | 2.86e-03 | 235 | 77 | 5 | PS50026 | |
| Domain | EGF | 2.86e-03 | 235 | 77 | 5 | SM00181 | |
| Domain | Ig_2 | 3.41e-03 | 73 | 77 | 3 | PF13895 | |
| Domain | EGF-like_dom | 3.66e-03 | 249 | 77 | 5 | IPR000742 | |
| Domain | SEA | 3.67e-03 | 22 | 77 | 2 | PF01390 | |
| Domain | IGv | 3.68e-03 | 75 | 77 | 3 | SM00406 | |
| Domain | EGF_1 | 4.05e-03 | 255 | 77 | 5 | PS00022 | |
| Pubmed | EPRS1 NCOA6 PPP2R1A GTF3C1 ANK3 RPS3 ARID2 GEMIN5 TAF4 MIDEAS PRPF40A | 4.71e-08 | 549 | 79 | 11 | 38280479 | |
| Pubmed | 9.14e-08 | 162 | 79 | 7 | 25826454 | ||
| Pubmed | HSPD1 EPRS1 HSPG2 NPTN CLU RPS3 PIGS SPTLC1 GEMIN5 TAF4 TMEM231 | 1.43e-07 | 613 | 79 | 11 | 22268729 | |
| Pubmed | NPTN PPP2R1A ARHGAP32 ANK3 CLU CTCF DCHS1 NCAM1 TSC1 SIRPA TAF4 RTN1 EPHA4 | 2.53e-07 | 963 | 79 | 13 | 28671696 | |
| Pubmed | ZNF512B HIPK3 HSPG2 NCOA6 PPP2R1A PTPRF ANK3 HIPK1 PRPF40A SON | 9.37e-07 | 591 | 79 | 10 | 15231748 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF512B HSPD1 EPRS1 NCOA6 CTCF RPS3 ARID2 NOL6 TAF4 MIDEAS PRPF40A SON | 1.60e-06 | 954 | 79 | 12 | 36373674 |
| Pubmed | HSPD1 EPRS1 PPP2R1A GTF3C1 CTCF RPS3 GEMIN5 TAF4 MIDEAS PRPF40A | 2.35e-06 | 655 | 79 | 10 | 35819319 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | HSPD1 NPTN IPO8 PTPRF CTCF RPS3 PIGS NOL6 SPTLC1 GEMIN5 NCAM1 SIRPA PRPF40A | 3.02e-06 | 1203 | 79 | 13 | 29180619 |
| Pubmed | ZNF512B HSPD1 HSPG2 NCOA6 PPP2R1A ARHGAP32 TSHZ3 GTF3C1 PITRM1 CTCF ARID2 TAF4 MIDEAS PRPF40A | 3.74e-06 | 1429 | 79 | 14 | 35140242 | |
| Pubmed | HSPD1 EPRS1 NPTN PPP2R1A ARHGAP32 ANK3 LRIG1 CLU RPS3 GEMIN5 NCAM1 TSC1 RTN1 PRPF40A | 3.80e-06 | 1431 | 79 | 14 | 37142655 | |
| Pubmed | The tumour-suppressive function of CLU is explained by its localisation and interaction with HSP60. | 5.09e-06 | 2 | 79 | 2 | 22012253 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF512B HSPD1 EPRS1 NCOA6 PPP2R1A MYPOP GTF3C1 ZBED4 CTCF TAF4 MIDEAS PRPF40A SON | 6.64e-06 | 1294 | 79 | 13 | 30804502 |
| Pubmed | 7.30e-06 | 117 | 79 | 5 | 17145500 | ||
| Pubmed | In vivo visualization and molecular targeting of the cardiac conduction system. | 7.50e-06 | 17 | 79 | 3 | 35951416 | |
| Pubmed | ZNF512B SLIT2 CLU CCNB3 CTCF ARID2 SPTLC1 SIGLEC1 TAF4 PRPF40A SLC40A1 SON | 7.94e-06 | 1116 | 79 | 12 | 31753913 | |
| Pubmed | 8.98e-06 | 18 | 79 | 3 | 29329290 | ||
| Pubmed | 9.97e-06 | 608 | 79 | 9 | 16713569 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.09e-05 | 332 | 79 | 7 | 32786267 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 10512748 | ||
| Pubmed | Update on the Regulation of HIPK1, HIPK2 and HIPK3 Protein Kinases by microRNAs. | 1.53e-05 | 3 | 79 | 2 | 29793420 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ZNF512B HSPD1 SLIT2 EPRS1 PPP2R1A GTF3C1 PTPRF RPS3 NOL6 PRPF40A SON | 1.98e-05 | 1024 | 79 | 11 | 24711643 |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 2.47e-05 | 377 | 79 | 7 | 38117590 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 3036828 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 25630557 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 24551271 | ||
| Pubmed | Fragile TIM-4-expressing tissue resident macrophages are migratory and immunoregulatory. | 3.05e-05 | 4 | 79 | 2 | 24983317 | |
| Pubmed | Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation. | 3.05e-05 | 4 | 79 | 2 | 34785661 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 21750111 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 18172549 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 5.02e-05 | 934 | 79 | 10 | 33916271 | |
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 36278864 | ||
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 29212956 | ||
| Pubmed | Molecular mechanism and cellular function of MHCII ubiquitination. | 5.07e-05 | 5 | 79 | 2 | 26085212 | |
| Pubmed | Cross-reactivity of anti-programmed death ligand 2 polyclonal antibody in mouse tissues. | 5.07e-05 | 5 | 79 | 2 | 23090063 | |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 5.08e-05 | 175 | 79 | 5 | 25756610 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 5.39e-05 | 942 | 79 | 10 | 31073040 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 5.46e-05 | 583 | 79 | 8 | 29844126 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 5.67e-05 | 430 | 79 | 7 | 35044719 | |
| Pubmed | 6.42e-05 | 34 | 79 | 3 | 18848646 | ||
| Pubmed | The Lipid-Modifying Enzyme SMPDL3B Negatively Regulates Innate Immunity. | 7.60e-05 | 6 | 79 | 2 | 26095358 | |
| Pubmed | Multimodal control of dendritic cell functions by nociceptors. | 7.60e-05 | 6 | 79 | 2 | 36996219 | |
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 20579985 | ||
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 9748262 | ||
| Pubmed | Alveolar macrophages and lung dendritic cells sense RNA and drive mucosal IgA responses. | 7.60e-05 | 6 | 79 | 2 | 19710454 | |
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 22275477 | ||
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 12529400 | ||
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 27792766 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HSPD1 EPRS1 PPP2R1A IPO8 GTF3C1 PITRM1 RPS3 NOL6 SPTLC1 GEMIN5 PRPF40A NBR1 | 8.63e-05 | 1425 | 79 | 12 | 30948266 |
| Pubmed | 8.99e-05 | 38 | 79 | 3 | 28680062 | ||
| Pubmed | HSPD1 GARIN5B EPRS1 MYPOP GTF3C1 ZBED4 NOL6 CFAP74 TSC1 TAF4 SH3D21 EPHA4 | 9.65e-05 | 1442 | 79 | 12 | 35575683 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | HSPD1 SLIT2 EPRS1 HSPG2 NPTN LRIG1 PITRM1 RPS3 PIGS SPTLC1 TMEM231 PRPF40A | 1.02e-04 | 1451 | 79 | 12 | 30550785 |
| Pubmed | New genetic associations detected in a host response study to hepatitis B vaccine. | HAVCR1 PPP2R1A HLA-DQB1 HLA-DQB2 TLR7 SIGLEC1 FCRL5 IL36G LRIT1 | 1.05e-04 | 824 | 79 | 9 | 20237496 |
| Pubmed | TLR7 Controls VSV Replication in CD169+ SCS Macrophages and Associated Viral Neuroinvasion. | 1.06e-04 | 7 | 79 | 2 | 30930901 | |
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 11034606 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 12242711 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 38689088 | ||
| Pubmed | 1.10e-04 | 331 | 79 | 6 | 29199018 | ||
| Pubmed | 1.21e-04 | 486 | 79 | 7 | 20936779 | ||
| Pubmed | 1.26e-04 | 844 | 79 | 9 | 25963833 | ||
| Pubmed | 1.30e-04 | 847 | 79 | 9 | 35850772 | ||
| Pubmed | 1.40e-04 | 44 | 79 | 3 | 31273033 | ||
| Pubmed | 1.41e-04 | 8 | 79 | 2 | 12435584 | ||
| Pubmed | Lrig2 Negatively Regulates Ectodomain Shedding of Axon Guidance Receptors by ADAM Proteases. | 1.41e-04 | 8 | 79 | 2 | 26651291 | |
| Pubmed | 1.41e-04 | 8 | 79 | 2 | 18586242 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.51e-04 | 351 | 79 | 6 | 38297188 | |
| Pubmed | Gene essentiality and synthetic lethality in haploid human cells. | 1.80e-04 | 229 | 79 | 5 | 26472760 | |
| Pubmed | Dynamic expression patterns of ECM molecules in the developing mouse olfactory pathway. | 1.82e-04 | 9 | 79 | 2 | 18570250 | |
| Pubmed | 2.05e-04 | 50 | 79 | 3 | 23658023 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 2.20e-04 | 714 | 79 | 8 | 28302793 | |
| Pubmed | 2.27e-04 | 10 | 79 | 2 | 19584108 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSPD1 EPRS1 PPP2R1A GTF3C1 RPS3 NOL6 GEMIN5 TSC1 MIDEAS IL36G SON | 2.37e-04 | 1353 | 79 | 11 | 29467282 |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 2.60e-04 | 248 | 79 | 5 | 24006456 | |
| Pubmed | 2.61e-04 | 551 | 79 | 7 | 34728620 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 2.64e-04 | 552 | 79 | 7 | 10737800 | |
| Pubmed | 2.74e-04 | 251 | 79 | 5 | 27507650 | ||
| Pubmed | 2.76e-04 | 11 | 79 | 2 | 18685789 | ||
| Pubmed | 2.76e-04 | 11 | 79 | 2 | 37572655 | ||
| Pubmed | 2.76e-04 | 11 | 79 | 2 | 29249358 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.82e-04 | 394 | 79 | 6 | 27248496 | |
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 3.00e-04 | 256 | 79 | 5 | 32698014 | |
| Pubmed | 3.06e-04 | 257 | 79 | 5 | 16335952 | ||
| Pubmed | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis. | 3.07e-04 | 141 | 79 | 4 | 32322062 | |
| Pubmed | HSPD1 EPRS1 GTF3C1 RPS3 HLA-DQB1 PIGS GEMIN5 NCAM1 PRPF40A NBR1 | 3.09e-04 | 1168 | 79 | 10 | 19946888 | |
| Pubmed | 3.16e-04 | 142 | 79 | 4 | 30809309 | ||
| Pubmed | 3.16e-04 | 754 | 79 | 8 | 35906200 | ||
| Pubmed | 3.18e-04 | 403 | 79 | 6 | 30562941 | ||
| Pubmed | USP7 controls NGN3 stability and pancreatic endocrine lineage development. | 3.18e-04 | 58 | 79 | 3 | 37117185 | |
| Pubmed | 3.31e-04 | 12 | 79 | 2 | 16540508 | ||
| Pubmed | HIV-1 Nef impairs MHC class II antigen presentation and surface expression. | 3.31e-04 | 12 | 79 | 2 | 11593029 | |
| Pubmed | Multiple influences on the migration of precerebellar neurons in the caudal medulla. | 3.31e-04 | 12 | 79 | 2 | 11807023 | |
| Pubmed | 3.31e-04 | 12 | 79 | 2 | 12970439 | ||
| Pubmed | 3.31e-04 | 12 | 79 | 2 | 16537918 | ||
| Pubmed | Regulation of neuronal migration by Dchs1-Fat4 planar cell polarity. | 3.31e-04 | 12 | 79 | 2 | 24998526 | |
| Pubmed | 3.31e-04 | 12 | 79 | 2 | 7494303 | ||
| Pubmed | The Opitz syndrome gene product MID1 assembles a microtubule-associated ribonucleoprotein complex. | 3.31e-04 | 12 | 79 | 2 | 18172692 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 3.34e-04 | 262 | 79 | 5 | 36880596 | |
| Pubmed | Establishment of fetomaternal tolerance through glycan-mediated B cell suppression. | 3.91e-04 | 13 | 79 | 2 | 35236989 | |
| Pubmed | 3.91e-04 | 13 | 79 | 2 | 38450283 | ||
| Pubmed | 4.55e-04 | 14 | 79 | 2 | 32515732 | ||
| Pubmed | Dystroglycan organizes axon guidance cue localization and axonal pathfinding. | 4.55e-04 | 14 | 79 | 2 | 23217742 | |
| Interaction | FEV interactions | 1.26e-05 | 203 | 77 | 7 | int:FEV | |
| Interaction | FBXO6 interactions | HSPD1 EPRS1 HSPG2 NPTN COL12A1 CLU RPS3 PIGS SPTLC1 GEMIN5 TAF4 TMEM231 | 1.65e-05 | 717 | 77 | 12 | int:FBXO6 |
| Cytoband | 5q33.2 | 3.45e-04 | 16 | 79 | 2 | 5q33.2 | |
| Cytoband | 14q23.1 | 3.01e-03 | 47 | 79 | 2 | 14q23.1 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.06e-09 | 161 | 54 | 9 | 593 | |
| GeneFamily | Fibronectin type III domain containing | 7.95e-06 | 160 | 54 | 6 | 555 | |
| GeneFamily | C1-set domain containing | 2.66e-04 | 42 | 54 | 3 | 591 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 4.47e-04 | 50 | 54 | 3 | 721 | |
| GeneFamily | Armadillo repeat containing|Importins | 1.30e-03 | 18 | 54 | 2 | 596 | |
| GeneFamily | CD molecules|Mucins | 1.77e-03 | 21 | 54 | 2 | 648 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 6.31e-03 | 394 | 54 | 5 | 471 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 7.64e-03 | 44 | 54 | 2 | 588 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-08 | 169 | 79 | 7 | 0f5e737b265ba333275a0cd289dab029a1542075 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-07 | 169 | 79 | 6 | aec1b4c7e973a31c53aaea47c2c05d24ce16aa4f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-06 | 189 | 79 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.24e-06 | 193 | 79 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-06 | 194 | 79 | 6 | ad72be9f6871b334e1f477d868c15e7792fadea5 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 1.35e-06 | 196 | 79 | 6 | 075e5746fa5cb121115a1d51b823c0fbf8d54305 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac|GI_small-bowel / Manually curated celltypes from each tissue | 1.43e-06 | 198 | 79 | 6 | 748db69d3c9774e44c0cc425d937d18b83af8312 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-06 | 133 | 79 | 5 | f6e9a1301a3379847b215303a9b0c028841e2cc0 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-06 | 133 | 79 | 5 | 292ecfcadbaf15e0d34a3ab9bf511ab1065888bd | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-06 | 157 | 79 | 5 | 14c4c61790eba6a388679e6d5011424d56cf3b5a | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.16e-05 | 166 | 79 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 1.54e-05 | 176 | 79 | 5 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.86e-05 | 183 | 79 | 5 | 27a57cd8ea924420e182f3d72f5b29b00dea8fa0 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 183 | 79 | 5 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.07e-05 | 187 | 79 | 5 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.12e-05 | 188 | 79 | 5 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | facs-MAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-05 | 191 | 79 | 5 | b4fba92f9bd1354a07fedfca7304a3757e6d5beb | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.29e-05 | 191 | 79 | 5 | 94c7da03e5264f4d73bb507ce339a935d90279a0 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.29e-05 | 191 | 79 | 5 | 24d75b7e1d6fb9d24aa7844f584ee888a449841f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 194 | 79 | 5 | be869e186386d03ebb670971dd24fa656b4b0edf | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 194 | 79 | 5 | 2224c7c943cfd5c1a329dfcf19d6e5ef8c49d85d | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 194 | 79 | 5 | 50c5fc349533281a426bc7227a8ea9eca8d11985 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.46e-05 | 194 | 79 | 5 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.46e-05 | 194 | 79 | 5 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 194 | 79 | 5 | 1662b110f84584e75150df0ac970e7df82f26e7e | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 194 | 79 | 5 | b31d6361fa939a92a4a3dc63c209ecd3eb514e6a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.52e-05 | 195 | 79 | 5 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.52e-05 | 195 | 79 | 5 | 799992721369357484300fe218aff075154c3148 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.52e-05 | 195 | 79 | 5 | e8fb552f9ab77b656c27abc66af523b56cd9f9ad | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 195 | 79 | 5 | cad21edd90bf3e2fefdf5773a59cb1a664a69ddd | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.52e-05 | 195 | 79 | 5 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.52e-05 | 195 | 79 | 5 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.59e-05 | 196 | 79 | 5 | 3fd5567ea14193181929134c377e8a38fb4f47fd | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.59e-05 | 196 | 79 | 5 | ce3709adbde7559b40c964888935914f66003247 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.59e-05 | 196 | 79 | 5 | 5fe6534af65d43eeacd4b031310242b4f706008b | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-05 | 196 | 79 | 5 | 8862964090f9a679a548103bfbb12e91295aae62 | |
| ToppCell | (3)_Macrophage_MARCOneg|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.65e-05 | 197 | 79 | 5 | b0ee2ce1179b60b4542559acb300a34295277dbc | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-05 | 197 | 79 | 5 | e0fc098bfb5a8b7824ae339f3adda30f78360d0b | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.65e-05 | 197 | 79 | 5 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.72e-05 | 198 | 79 | 5 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.72e-05 | 198 | 79 | 5 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | 11.5-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 2.72e-05 | 198 | 79 | 5 | 23783572c22c24d9fb8e14dc1f3852d2094157df | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.72e-05 | 198 | 79 | 5 | 6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f | |
| ToppCell | Parenchyma_COVID-19|World / Sample group, Lineage and Cell type | 2.72e-05 | 198 | 79 | 5 | 45ab554e6d0399b3182f089a25b2adf96de1144b | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.78e-05 | 199 | 79 | 5 | 7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac|GI_small-bowel / Manually curated celltypes from each tissue | 2.78e-05 | 199 | 79 | 5 | 8990a3d69e24cb3aaba9d6def3d0be9ee973436d | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 2.78e-05 | 199 | 79 | 5 | 96070b5ffcbab4952970f43b536969ddd2ca5d14 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-05 | 199 | 79 | 5 | c684530d4d8073337379c2a24e5e54297fb13691 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_naive|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-05 | 199 | 79 | 5 | 8bc07beace200ae2ad41e932b72fdcc7ff08b812 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.78e-05 | 199 | 79 | 5 | f2ad641f36c577ff7019e88ad6b73ed7e46d8c74 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.85e-05 | 200 | 79 | 5 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.85e-05 | 200 | 79 | 5 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.85e-05 | 200 | 79 | 5 | 27f498bcd706d0751091662996795b5270e46f14 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-04 | 142 | 79 | 4 | 5ef69032ed7dc5f2244b84e8c6662290bf59a34b | |
| ToppCell | Adult-Immune-dendritic_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.36e-04 | 147 | 79 | 4 | 7cc4f74dd7a86247db8dc049ed7eadeb53825a96 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.43e-04 | 149 | 79 | 4 | 3904f8ce9078de238600ceceee0116af52256a1c | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK_CD56bright|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.51e-04 | 151 | 79 | 4 | 2470162f4b56bc505db166a6eb0fa54847759df8 | |
| ToppCell | NS-moderate-d_0-4-Myeloid-Monocyte-derived_DC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.54e-04 | 152 | 79 | 4 | ce944f7c1444fd0cb793db183b96818e37342b24 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.58e-04 | 59 | 79 | 3 | 74590437b1d9a2a8fe56d79b2e66803528b81298 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.58e-04 | 153 | 79 | 4 | 64d0f37d7af9b76234f683379e3689771f71fe70 | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK_CD56bright|World / disease group, cell group and cell class (v2) | 1.58e-04 | 153 | 79 | 4 | aff5c8ab1fb4ebc324cec02cf562b7484bb10db8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 155 | 79 | 4 | 90e629681a72baacc7981b82883866a487638dbc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 155 | 79 | 4 | e7f49e2fdaf184fa6b4e685518004e7deff1316d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 155 | 79 | 4 | 5a872ca70ae8c30b57f45a6772d7bf565e0c2663 | |
| ToppCell | facs-GAT-Fat-24m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 157 | 79 | 4 | c4a0b6c95d353691fd2846002ce4bc7c2b0edd1c | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.88e-04 | 160 | 79 | 4 | ac3f56f8ab8efd11c4b4868a828db05c23ac762f | |
| ToppCell | facs-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 161 | 79 | 4 | 45591addc765760db6029ac19e80573373d1d917 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 161 | 79 | 4 | 8741b91a62c9a8ce377ef6533d323b65beb93c63 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 161 | 79 | 4 | 9cf1dcf0e7ca9e35c46c094a6b78f98d1f6b9276 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-04 | 163 | 79 | 4 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-04 | 163 | 79 | 4 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.02e-04 | 163 | 79 | 4 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | facs-Skin-nan-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 164 | 79 | 4 | 7a65c7a6dbe5fb9067f83efafbb7ec8206d79325 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 165 | 79 | 4 | 84eca6a0f5e996b6955ae79fa102af239098fe8f | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 165 | 79 | 4 | af59a095ecc6758abc13d763c00e44447c488167 | |
| ToppCell | mild-Lymphocytic-B_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.21e-04 | 167 | 79 | 4 | 0811f7559c2a7151693771e52e14af3978997118 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.27e-04 | 168 | 79 | 4 | eba865465feb0f42055bb8f98946050eeb03d177 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 169 | 79 | 4 | 44d841fd997a6f26104f16cd00223ecce8352f43 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 169 | 79 | 4 | 1000eaf5158596b4898bedcc802b31db76b05a48 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 169 | 79 | 4 | 83b854fa8fd9017df8f9207d9ced260eee98e8c1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-04 | 170 | 79 | 4 | 60bbd738c12e64e483485586c30057304884f5a6 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 2.37e-04 | 170 | 79 | 4 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Immune_cells-Dendritic_cells|World / Lineage and Cell class | 2.37e-04 | 170 | 79 | 4 | 094dc211d80c89ecb1010855f1fe6eeb71bf0e20 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-04 | 170 | 79 | 4 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 171 | 79 | 4 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 171 | 79 | 4 | 25493a4a7b636920e2cfd984542cc500709c9dcf | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 171 | 79 | 4 | 508b41e3ad2638f9dd546d251b13ff60fc8c3207 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-04 | 172 | 79 | 4 | f0e767a20d93e546ce278db67dbd779cc68af533 | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 172 | 79 | 4 | 4fe5b91e4871bc6c5be57eb5b8bb04815b2fb80d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-04 | 172 | 79 | 4 | 6c17a1e586a72d1bd80c20c06370429c61dc9f85 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-04 | 172 | 79 | 4 | f6b4754a7e4b3e38030316a0ae00d932bfa87e41 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 2.53e-04 | 173 | 79 | 4 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.53e-04 | 173 | 79 | 4 | f135cc9dcf34f33ced3210171ab40ae6d77cfae0 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.53e-04 | 173 | 79 | 4 | 23248019c819f6e38337dcc4edb763ef1992e89e | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|(0)_Normal/No_Treatment / Stress and Cell class | 2.53e-04 | 173 | 79 | 4 | c2a0f674681836b5a868c13f67caa7d555ef6519 | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-04 | 173 | 79 | 4 | 63f03abca84ae021ff34ff34537838aa8a1ccd11 | |
| ToppCell | facs-Heart-LA-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 174 | 79 | 4 | 30c083fe4711735e83dccfd00fcd746ae673d353 | |
| ToppCell | facs-Heart-LA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 174 | 79 | 4 | 46d19c1144fff19be682b7ba59d4c3e014f79e15 | |
| ToppCell | facs-Heart-LA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 174 | 79 | 4 | 1802a52552256d1e25d8b328ba62dcfe41671900 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-04 | 174 | 79 | 4 | f520b79d277e286c9bb5d091e6c94e7ec7e46699 | |
| Drug | (1R,3R)-5-[(2E)-2-[(1E,7aS)-1-(6-hydroxy-6-methylheptan-2-ylidene)-7a-methyl-2,3,3a,5,6,7-hexahydroinden-4-ylidene]ethylidene]-2-methylenecyclohexane-1,3-diol | 4.56e-06 | 10 | 78 | 3 | CID011553431 | |
| Disease | frailty measurement | 3.85e-07 | 23 | 78 | 4 | EFO_0009885 | |
| Disease | type 1 diabetes mellitus, latent autoimmune diabetes in adults | 4.12e-05 | 4 | 78 | 2 | EFO_0009706, MONDO_0005147 | |
| Disease | narcolepsy-cataplexy syndrome, age at onset | 6.86e-05 | 5 | 78 | 2 | EFO_0004847, MONDO_0016158 | |
| Disease | HPV seropositivity | 6.86e-05 | 5 | 78 | 2 | EFO_0004510 | |
| Disease | level of coiled-coil domain-containing protein 134 in blood serum | 6.86e-05 | 5 | 78 | 2 | OBA_2044258 | |
| Disease | Varicella zoster virus seropositivity | 6.86e-05 | 5 | 78 | 2 | EFO_0009340 | |
| Disease | lupus nephritis | 9.16e-05 | 33 | 78 | 3 | EFO_0005761 | |
| Disease | antibody measurement, Epstein-Barr virus infection | 1.03e-04 | 6 | 78 | 2 | EFO_0000769, EFO_0004556 | |
| Disease | pneumocystosis (biomarker_via_orthology) | 1.03e-04 | 6 | 78 | 2 | DOID:11339 (biomarker_via_orthology) | |
| Disease | pemphigus | 1.03e-04 | 6 | 78 | 2 | EFO_1000749 | |
| Disease | late-onset Alzheimers disease | 1.26e-04 | 292 | 78 | 6 | EFO_1001870 | |
| Disease | lymphoid leukemia | 1.40e-04 | 38 | 78 | 3 | EFO_0004289 | |
| Disease | antinuclear antibody measurement | 1.44e-04 | 7 | 78 | 2 | EFO_0005949 | |
| Disease | Anti-Helicobacter pylori IgG measurement | 1.44e-04 | 7 | 78 | 2 | EFO_0009352 | |
| Disease | cervical cancer | 1.64e-04 | 40 | 78 | 3 | MONDO_0002974 | |
| Disease | IgG index | 1.91e-04 | 8 | 78 | 2 | EFO_0006929 | |
| Disease | cardiovascular measurement, left ventricular function | 1.91e-04 | 8 | 78 | 2 | EFO_0004295, EFO_0004298 | |
| Disease | PAX-interacting protein 1 measurement | 1.91e-04 | 8 | 78 | 2 | EFO_0801868 | |
| Disease | soluble CD163 measurement | 1.91e-04 | 8 | 78 | 2 | EFO_0020072 | |
| Disease | gdnf family receptor alpha-1 measurement | 1.91e-04 | 8 | 78 | 2 | EFO_0020400 | |
| Disease | fibroblast growth factor 23 measurement | 2.03e-04 | 43 | 78 | 3 | EFO_0009381 | |
| Disease | zinc fingers and homeoboxes protein 3 measurement | 2.45e-04 | 9 | 78 | 2 | EFO_0803299 | |
| Disease | Epstein Barr virus nuclear antigen 1 IgG measurement | 2.45e-04 | 9 | 78 | 2 | EFO_0007790 | |
| Disease | inclusion body myositis | 2.45e-04 | 9 | 78 | 2 | EFO_0007323 | |
| Disease | head and neck malignant neoplasia | 2.45e-04 | 9 | 78 | 2 | EFO_0006859 | |
| Disease | HLA class II histocompatibility antigen, DQ alpha 2 chain measurement | 2.45e-04 | 9 | 78 | 2 | EFO_0801686 | |
| Disease | seropositivity measurement | 2.45e-04 | 9 | 78 | 2 | EFO_0007034 | |
| Disease | latent autoimmune diabetes in adults, type 2 diabetes mellitus | 2.45e-04 | 9 | 78 | 2 | EFO_0009706, MONDO_0005148 | |
| Disease | proteinuria (biomarker_via_orthology) | 3.06e-04 | 10 | 78 | 2 | DOID:576 (biomarker_via_orthology) | |
| Disease | peptidoglycan recognition protein 1 measurement | 3.06e-04 | 10 | 78 | 2 | EFO_0020624 | |
| Disease | CCL19 measurement | 3.06e-04 | 10 | 78 | 2 | EFO_0009415 | |
| Disease | cervical carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3 | 3.06e-04 | 10 | 78 | 2 | EFO_0001061, EFO_1000166 | |
| Disease | secreted and transmembrane protein 1 measurement | 3.06e-04 | 10 | 78 | 2 | EFO_0021852 | |
| Disease | C-reactive protein measurement | NCOA6 MYPOP LRFN2 PTPRF ANK3 HLA-DQB1 HLA-DQB2 SLC38A4 TAF4 IL36G ARMH4 | 3.21e-04 | 1206 | 78 | 11 | EFO_0004458 |
| Disease | chronic bronchitis | 3.74e-04 | 11 | 78 | 2 | EFO_0006505 | |
| Disease | apolipoprotein M measurement | 3.74e-04 | 11 | 78 | 2 | EFO_0021945 | |
| Disease | cAMP-specific 3',5'-cyclic phosphodiesterase 4D measurement | 3.74e-04 | 11 | 78 | 2 | EFO_0020224 | |
| Disease | head and neck squamous cell carcinoma | 3.74e-04 | 11 | 78 | 2 | EFO_0000181 | |
| Disease | pars orbitalis volume measurement | 3.74e-04 | 11 | 78 | 2 | EFO_0010320 | |
| Disease | uveitis (implicated_via_orthology) | 3.74e-04 | 11 | 78 | 2 | DOID:13141 (implicated_via_orthology) | |
| Disease | phospholipids in large LDL measurement | 3.78e-04 | 53 | 78 | 3 | EFO_0022174 | |
| Disease | diet measurement | NCOA6 PTPRF ANK3 MUC17 HLA-DQB1 HLA-DQB2 ARID2 PIGS NCAM1 EPHA4 | 4.35e-04 | 1049 | 78 | 10 | EFO_0008111 |
| Disease | rac GTPase-activating protein 1 measurement | 4.48e-04 | 12 | 78 | 2 | EFO_0801985 | |
| Disease | phospholipids in LDL measurement | 4.94e-04 | 58 | 78 | 3 | EFO_0022294 | |
| Disease | phospholipids in small LDL measurement | 5.19e-04 | 59 | 78 | 3 | EFO_0022297 | |
| Disease | rheumatoid arthritis, smoking status measurement, ACPA-positive rheumatoid arthritis | 5.28e-04 | 13 | 78 | 2 | EFO_0000685, EFO_0006527, EFO_0009459 | |
| Disease | Genetic chronic primary adrenal insufficiency | 5.28e-04 | 13 | 78 | 2 | Orphanet_101960 | |
| Disease | Schizophrenia | 5.32e-04 | 883 | 78 | 9 | C0036341 | |
| Disease | oral cavity cancer | 6.15e-04 | 14 | 78 | 2 | EFO_0005570 | |
| Disease | C-C motif chemokine 19 measurement | 6.15e-04 | 14 | 78 | 2 | EFO_0008047 | |
| Disease | oligoclonal band measurement, multiple sclerosis | 6.15e-04 | 14 | 78 | 2 | EFO_0005206, MONDO_0005301 | |
| Disease | liver neoplasm | 7.08e-04 | 15 | 78 | 2 | EFO_1001513 | |
| Disease | Non-steroidal anti-inflammatory and antirheumatic product use measurement | 7.08e-04 | 15 | 78 | 2 | EFO_0009935 | |
| Disease | Churg-Strauss syndrome | 7.08e-04 | 15 | 78 | 2 | EFO_0007208 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.18e-04 | 152 | 78 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | pemphigus vulgaris | 8.08e-04 | 16 | 78 | 2 | EFO_0004719 | |
| Disease | gastroparesis | 8.08e-04 | 16 | 78 | 2 | EFO_1000948 | |
| Disease | Cannabis use | 8.08e-04 | 16 | 78 | 2 | EFO_0007585 | |
| Disease | Endometrioma | 8.90e-04 | 161 | 78 | 4 | C0269102 | |
| Disease | Endometriosis | 8.90e-04 | 161 | 78 | 4 | C0014175 | |
| Disease | nephrotic syndrome | 8.92e-04 | 71 | 78 | 3 | EFO_0004255 | |
| Disease | Antihistamine use measurement | 9.14e-04 | 17 | 78 | 2 | EFO_0009943 | |
| Disease | high altitude adaptation | 9.14e-04 | 17 | 78 | 2 | EFO_0009105 | |
| Disease | response to interferon-beta, anti-drug antibody measurement | 9.14e-04 | 17 | 78 | 2 | EFO_0010559, GO_0035456 | |
| Disease | Graves disease, thyrotoxic periodic paralysis | 9.14e-04 | 17 | 78 | 2 | EFO_0004237, MONDO_0019201 | |
| Disease | serum IgG measurement | 1.03e-03 | 18 | 78 | 2 | EFO_0004565 | |
| Disease | tropical spastic paraparesis | 1.03e-03 | 18 | 78 | 2 | EFO_0007527 | |
| Disease | Carcinoma of bladder | 1.03e-03 | 18 | 78 | 2 | C0699885 | |
| Disease | asparaginase hypersensitivity | 1.13e-03 | 77 | 78 | 3 | EFO_0004881 | |
| Disease | hepatitis B virus infection | 1.15e-03 | 19 | 78 | 2 | EFO_0004197 | |
| Disease | carotid artery disease (is_marker_for) | 1.15e-03 | 19 | 78 | 2 | DOID:3407 (is_marker_for) | |
| Disease | angiopoietin-1 receptor measurement | 1.15e-03 | 19 | 78 | 2 | EFO_0010600 | |
| Disease | age of onset of asthma | 1.22e-03 | 79 | 78 | 3 | OBA_2001001 | |
| Disease | neoplasm of mature B-cells | 1.27e-03 | 20 | 78 | 2 | EFO_0000096 | |
| Disease | polymyositis | 1.27e-03 | 20 | 78 | 2 | EFO_0003063 | |
| Disease | Autoimmune Hepatitis | 1.40e-03 | 21 | 78 | 2 | EFO_0005676 | |
| Disease | platelet measurement | 1.50e-03 | 315 | 78 | 5 | EFO_0005036 | |
| Disease | C-peptide measurement | 1.54e-03 | 22 | 78 | 2 | EFO_0005187 | |
| Disease | Henoch-Schoenlein purpura | 1.54e-03 | 22 | 78 | 2 | EFO_1000965 | |
| Disease | ubiquitin carboxyl-terminal hydrolase 25 measurement | 1.54e-03 | 22 | 78 | 2 | EFO_0021881 | |
| Disease | serum iron measurement | 1.55e-03 | 86 | 78 | 3 | EFO_0006332 | |
| Disease | feeling nervous measurement | 1.61e-03 | 87 | 78 | 3 | EFO_0009597 | |
| Disease | remission, hepatitis C virus infection | 1.68e-03 | 23 | 78 | 2 | EFO_0003047, EFO_0009785 | |
| Disease | gestational diabetes | 1.68e-03 | 23 | 78 | 2 | EFO_0004593 | |
| Disease | age-related hearing impairment | 1.70e-03 | 324 | 78 | 5 | EFO_0005782 | |
| Disease | visceral adipose tissue measurement | 1.74e-03 | 481 | 78 | 6 | EFO_0004765 | |
| Disease | chronic hepatitis B virus infection | 1.83e-03 | 24 | 78 | 2 | EFO_0004239 | |
| Disease | drug-induced liver injury | 1.83e-03 | 24 | 78 | 2 | EFO_0004228 | |
| Disease | lymphoma | 1.83e-03 | 24 | 78 | 2 | EFO_0000574 | |
| Disease | pre-eclampsia (is_implicated_in) | 1.99e-03 | 25 | 78 | 2 | DOID:10591 (is_implicated_in) | |
| Disease | Abnormality of refraction | 2.03e-03 | 673 | 78 | 7 | HP_0000539 | |
| Disease | lysophosphatidylethanolamine 16:0 measurement | 2.15e-03 | 26 | 78 | 2 | EFO_0010366 | |
| Disease | proline measurement | 2.15e-03 | 26 | 78 | 2 | EFO_0009773 | |
| Disease | L lactate dehydrogenase measurement | 2.15e-03 | 26 | 78 | 2 | EFO_0004808 | |
| Disease | Alzheimer disease, age at onset | 2.18e-03 | 343 | 78 | 5 | EFO_0004847, MONDO_0004975 | |
| Disease | Hodgkins lymphoma, multiple myeloma, non-Hodgkins lymphoma | 2.49e-03 | 28 | 78 | 2 | EFO_0000183, EFO_0001378, EFO_0005952 | |
| Disease | chronic kidney disease (biomarker_via_orthology) | 2.49e-03 | 28 | 78 | 2 | DOID:784 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IEFTIPTAVTIEVEP | 31 | Q6ZRG5 | |
| PPLESLATVEETVVR | 91 | P30153 | |
| PVTVPVATTSVEELQ | 121 | P49711 | |
| LTPRETVVPSVDIIS | 776 | Q8IZF6 | |
| TTVVPLSFEVTPTVE | 526 | Q86TY3 | |
| PLIIAVTTVAITEPE | 526 | Q8IZF3 | |
| PVSTSVVRVDSVPDV | 616 | Q68CP9 | |
| PVTTPEEIAQVATIS | 161 | P10809 | |
| EVTPVVASTTVVPNI | 116 | Q8WWL7 | |
| VLPSLTVSRVIIPVS | 376 | Q6P387 | |
| DISSTVPIPEEEVVT | 71 | O15131 | |
| LLVTEAPSKPITVTV | 1761 | P98160 | |
| PQSSVVPVTVTVLDV | 2581 | Q96JQ0 | |
| ETPSLVVPLEDRVVS | 691 | Q96JA1 | |
| PPVSVITIRSDTDEE | 901 | Q86Z02 | |
| PVPELSTDTVINVIT | 116 | Q92484 | |
| PEETVPFVVTLRASV | 1496 | Q6ZU64 | |
| EPLEVTTNTVPSRII | 526 | P54764 | |
| VEPTVTISPSRTEAL | 126 | P05538 | |
| DTISLSVIVPVSRPI | 646 | Q96RD9 | |
| RETPIVTVTPSSVSA | 196 | Q02505 | |
| PVSTLVTTLPITITR | 1441 | Q02505 | |
| VVRVPSVPETELTDQ | 116 | Q9H6R4 | |
| ISVTLPPRVSEVIGT | 911 | A7KAX9 | |
| TIIIADSPSPAVSVI | 856 | Q9H422 | |
| ASETVISLIVTEPPT | 336 | Q9P2V4 | |
| RPVSSIIDVDLVPET | 141 | Q9BYG4 | |
| PEREVIVETISNPVT | 3156 | Q96RW7 | |
| PVVPEPEVTSIVATV | 311 | O75400 | |
| PTSVRSIVTTLVPSE | 1911 | Q14686 | |
| TTLQRRVEPTVTISP | 121 | P01920 | |
| RVEPTVTISPSRTEA | 126 | P01920 | |
| PRSDSVTPVTVAVIT | 46 | Q9NZH8 | |
| DLTSEPVTVREVTLP | 1551 | Q99715 | |
| VPIPPVITETRTEVV | 2156 | Q12955 | |
| IIPVSVPVRTVDPTE | 526 | Q6PJG2 | |
| VIPESSEVREVQLPT | 566 | Q9Y4K1 | |
| TTVIPPSEEQTEITL | 731 | Q9C0B2 | |
| LKVEVTPTVPRISRT | 301 | Q8IXS8 | |
| PPIDLVVTETTATSV | 321 | P10586 | |
| EIFRTIIDRTVPPET | 231 | O15397 | |
| IVVTITTSPALDSPV | 66 | Q8NGB2 | |
| LLTTPVEISTPVTIS | 236 | Q685J3 | |
| TPLTSVPVSTRLVVS | 1101 | Q685J3 | |
| TTILVSTTPVTRFPE | 3756 | Q685J3 | |
| LMVPVTVVFTRESVP | 61 | Q96S52 | |
| VRITITLTNELPPTS | 191 | Q96J94 | |
| QITTPVKITLTEIEP | 276 | Q16799 | |
| LETRVIGTSETPIII | 111 | Q96S79 | |
| TPIIARQVTPTTIIK | 511 | O00268 | |
| ELAEPIAIRPTSETV | 1111 | P07814 | |
| SIPENSIIPEETLTV | 311 | A4FU49 | |
| REVSPEPIVSTVARL | 351 | Q8N103 | |
| TSQTLETVPLIPEVV | 801 | Q14596 | |
| TTPIVTTVPTVTTVR | 131 | Q96D42 | |
| EPTIPVTELDVVLTA | 566 | Q5JRX3 | |
| LSETIRVPPTLEVTQ | 246 | P78324 | |
| GVEVRVTPTRTEIII | 36 | P23396 | |
| IVPETSPESVPIISV | 441 | Q9NP59 | |
| IIPIQEPDVTTTASR | 796 | P14410 | |
| TVTSVKVSELREIPP | 741 | Q8NHU6 | |
| TVPIVLFPIRTSVIT | 426 | Q969I6 | |
| VRPVPTTVRFVDSLI | 6 | Q9GZT8 | |
| PPSIRVVVTVEQTEE | 441 | O15269 | |
| IPVISTSETSVPLKV | 306 | Q499Z3 | |
| DSDPITVTVPVEVSR | 411 | P10909 | |
| VIVCDVVSSLPPTII | 136 | P13591 | |
| LSEITTAEAEPVVPR | 486 | Q92574 | |
| TTLPVEEPIVSTDEV | 136 | Q8WVR3 | |
| VPRSDSVAILETIPV | 236 | Q9P2N2 | |
| TVIESSPESPVTITE | 616 | Q8TEQ6 | |
| VTSEEVIIRDSPVLP | 151 | Q9Y639 | |
| LTEIPTNLPETITEI | 291 | O94813 | |
| TLVTVTEEPRVPTIA | 131 | Q9BZZ2 | |
| VTAVPTVLPSTLTEL | 216 | Q9NYK1 | |
| VETPVTPTITTLLDE | 426 | Q63HK5 | |
| VSRPIVVSKPVTVSR | 296 | Q96KM6 | |
| VVTTIPVTVTPRGDL | 296 | Q9H6L2 | |
| RPVSLFSTPVVEEVE | 2056 | Q12789 | |
| VPAVTTPVLAESILE | 1331 | P18583 | |
| IPSPDRITEESVSVV | 216 | O75132 | |
| PEPVVTVRTQETDVV | 586 | Q8N5Q1 | |
| PPERAVLVSEVTTTS | 421 | Q9ULH4 | |
| IVITTEPTDDTTVPE | 246 | Q9NPC6 | |
| VEITPEPVSVVAAVV | 331 | Q86VE0 |